Equity intelligence report • May 23, 2026
Zoetis Inc. is grappling with significant financial challenges as its stock dropped 5% following a disappointing Q1 2026 earnings report that missed Wall Street expectations. The company has revised its revenue and profit forecasts downward due to decreased demand for its animal healthcare products, particularly in the U.S. companion animal market. This downturn follows a series of setbacks, including analyst downgrades and a stock price plummet of over 21% linked to prior earnings, leading to lowered price targets and rising concerns about competitive pressures. Despite maintaining a dividend commitment and pursuing acquisitions for growth, Zoetis's market position remains precarious amid these ongoing struggles.
Click a month on the chart to update the report below.
